bpc-157 evidence human clinical trials review and the Difference Between an Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded bpc-157 human clinical trials evidence
Description
A consensus paper
BPC-157 is a stable synthetic pentadecapeptide investigated in animal models for gastrointestinal protection and tendon, ligament, muscle and bone healing [1] [3] , while TB-500 is a synthetic fragment related to thymosin 4 studied for cell migration, angiogenesis and wound closure [4] [5]
An overall favorable effect on inflammation control was predicted for B12 treated cultures of MOD ( Figure 6B and Figure S5 ) and SEV ( Figure 6C and Figure S6 ) groups
The dosage calculation guide explains this principle in depth
